Chiang Mai Ram Medical Business Valuation

Q: What is the Fair Price of CMR-R when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

CMR-R (THB1.94) is trading above our estimate of [[fair value]] (THB1.38)

Is CMR-R undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

0/6

Valuation Score 0/6

Below Fair Value
Significantly Below Fair Value
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of CMR-R when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: CMR-R (THB1.94) is trading above our estimate of fair value (THB1.38)

Significantly Below Fair Value: CMR-R is trading above our estimate of fair value.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for CMR-R?

Other financial metrics that can be useful for relative valuation.

The above table shows the n/a ratio for CMR-R. This is calculated by dividing CMR-R's market cap by their current preferred multiple.
What is CMR-R's n/a Ratio?
n/a	0x
n/a	n/a
Market Cap	฿7.90b

CMR-R key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue	2.1x
Enterprise Value/EBITDA	10.2x
PEG Ratio	n/a

Price to Earnings Ratio vs Peers

How does CMR-R's PE Ratio compare to its peers?

The above table shows the PE ratio for CMR-R vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
Company	Forward PE	Estimated Growth	Market Cap
Peer Average	20.8x
WPH Wattanapat Hospital Trang	36.2x	n/a	฿7.9b
TNH Thai Nakarin Hospital	15.1x	n/a	฿6.6b
EKH Ekachai Medical Care	16.5x	2.9%	฿5.1b
RJH Rajthanee Hospital	15.5x	-4.8%	฿7.0b
CMR-R Chiang Mai Ram Medical Business	28.3x	n/a	฿7.9b

Price-To-Earnings vs Peers: CMR-R is expensive based on its Price-To-Earnings Ratio (28.3x) compared to the peer average (20.8x).

Price to Earnings Ratio vs Industry

How does CMR-R's PE Ratio compare vs other companies in the TH Healthcare Industry?

0 Companies	Price / Earnings	Estimated Growth	Market Cap
Industry Avg.	n/a	10.6%
	n/a	n/a	n/a

Fetching data

0 Companies	Price / Earnings	Estimated Growth	Market Cap
Industry Avg.	n/a	10.6%
	n/a	n/a	n/a

No more companies

Price-To-Earnings vs Industry: CMR-R is expensive based on its Price-To-Earnings Ratio (28.3x) compared to the TH Healthcare industry average (24.7x).

Price to Earnings Ratio vs Fair Ratio

What is CMR-R's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

CMR-R PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio	28.3x
Fair PE Ratio	n/a

Price-To-Earnings vs Fair Ratio: Insufficient data to calculate CMR-R's Price-To-Earnings Fair Ratio for valuation analysis.

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Analyst Forecast: Insufficient data to show price forecast.